Two outlets cover the same theme: a minority analyst position that does not recommend buying SpaceX stock. The reporting focuses less on specific operational setbacks and more on investor risks. Across the sources, the central reservations are SpaceX’s high implied or stated valuation and uncertainties tied to future regulation. The articles describe that, while many market participants view SpaceX as a leading private space company, some analysts remain cautious because the price investors pay may be difficult to justify relative to future growth and earnings. They also note that regulatory developments—potentially involving how private space companies are supervised, how launches and operations are overseen, or how commercial space activities are permitted—could affect costs, timelines, or profitability. The coverage presents this as a contrast to broader enthusiasm, emphasizing that at least one analyst is not rating the stock a buy and pointing to valuation pressure and regulatory risk as key drivers of that stance.